SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-055084
Filing Date
2015-06-19
Accepted
2015-06-19 16:18:21
Documents
2
Period of Report
2015-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2115
2 EX-24 DOCUMENT attachment1.htm EX-24 2973
  Complete submission text file 0001209191-15-055084.txt   6427
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GENZYME CORP. 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address
BOUDREAUX GAIL (Reporting) CIK: 0001287920 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26770 | Film No.: 15942615